Advanced analytics and artificial intelligence (AI) will help make mRNA vaccines and therapeutics better by allowing biopharma engineers to fine-tune the enzymes used to manufacture such products.

The growing push to rethink invasive plant management is getting fresh attention thanks to a new book from the Missouri Botanical Garden, 'Love Them to Death: Turning Invasive Plants into Local ...

CREATE Medicines ("CREATE") broadens clinical programs and capabilities to expand therapeutic potential and improve patient outcomes Therapies tolerably program immune cells inside the human body, ...

WASHINGTON, D.C. - Kennedy Center President Ric Grenell blamed Jimmy Kimmel's one-sided rhetoric for his temporary late-night TV suspension on Saturday at the Kennedy Center Gala benefiting the ...

Not revised: This Reviewed Preprint includes the authors’ original preprint (without revision), an eLife assessment, and public reviews. The manuscript by Xu et al. reported base-resolution mapping of ...

Novo Nordisk is looking to add to its obesity pipeline, teaming up with California biotech Replicate Bioscience to design and develop an RNA-based treatment for obesity and diabetes. The partners did ...

A few years after it was founded with the aim of taking RNA therapies to the next level, Arnatar Therapeutics Inc. emerged from stealth, disclosing a $52 million series A round raised in 2024 as well ...